- Joined
- 5 July 2005
- Posts
- 20
- Reactions
- 0
ctp6360 said:See I am completely new at this stuff but I don't know why anyone could possibly recommend a buy on RHT, at least from a technical perspective anyway.
Someone help me out here, this is what I see from the graph just by looking at it:
1) From Feb 05 it has been on a large downward trend
2) May 3 when this Stock was reviewed it was at its absolute all-time low
There is no indication that I can see that this stock is going to go up? And since we have the luxury of seeing what happened since may 3 we see that it has found support at about 0.135 and is going sideways.
So I guess the reviewer predicted at least the end of the current downward trend but I still don't see any inidication that it is going to go up from here?
Can someone tell me what I'm missing here?
Snake Pliskin said:It might be range trading now. Look at the volume. :bier:
samsterchan said:The share price has shown some weakness in the past week.
I bought in yesterday at 11 cents and am waiting for it to go up to 15 cents.
This is essentially a sound company with all the right distribution channels and low set up costs - the fact that they have gone into liver fibrosis is a good sign.
Watch this company - the next market sensitive news shouldn't be very far away, once that happens, this will shoot up for sure.
Aspect Huntley has recommended them several times..... see link below
http://www.aspecthuntley.com.au/doc...zaWduYWwvZXJyb3JwYWdlcy9wZGZkZWxheWVkLmpzcA==
Also, the former federal health minister sits on the board, so they do have some experienced people with clout.
More distribution agreements with DCA Group and the big pharma players should be announced soon.
No posts on this one since 2014
Intraday high of 0.054 and close of 0.035 today … Up 20% ….. Big Volume.
ASX Price Query shed little light ….. wait and see after the dust settles I guess
It looks like RHT is making real strides in getting FerriSmart® ready for commercial distribution. Although there is no indication yet of anticipated revenue it is clear that the company believes there is a significant market in the USA.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?